Olga Petryna DrPetryna
3 years 1 month ago
Abst1625 #ACR21 @RheumNow study of kids w/covid induced MIS-C: 91% w/shock & GI ax, conjunctivitis & mucocutaneous involvement. ⬆️CRP,D-Dimer, Troponin, &BNP. On ECHO, 36% had myocardial dysfunction &27% coronary artery abnormalities. 64% required ICU admiss. Rx IVIG& steroids
Eric Dein ericdeinmd
3 years 1 month ago
#ACR21 Thieves! TM11. Belly pain in patient with RA nodules:
⭐️ A: rheumatoid nodulosis of pancreas and duodenum.
Great case!
@Rheumnow https://t.co/PuO4tka3FJ
Mrinalini Dey DrMiniDey
3 years 1 month ago
Excellent overview on assessment of patients with #PsA by @AlexisOgdie!
Really clear and easy-to-follow slides to add structure to clinical assessment.
#ACR21 @RheumNow https://t.co/XGZrCxOukm
Richard Conway RichardPAConway
3 years 1 month ago
Sub-analysis of ICHIBAN study looking at adverse events in tocilizumab treated patients with/without steroids. Steroids associated with small increase in adverse events across board. Abstr#1693 #ACR21 @RheumNow https://t.co/ldiovirKpo
Mrinalini Dey DrMiniDey
3 years 1 month ago
What is the effect of #avacopan on renal function in pts with #ANCA #vasculitis?
👉🏼Results from ADVOCATE show greater recovery of kidney function with avacopan vs steroids
👉🏼Particularly marked in pts with CKD4 and eGFR<60
Abs#L14 #ACR21 @RheumNow
https://t.co/5z7YulxVAj https://t.co/LnJr4gLuTV
sheila RHEUMarampa
3 years 1 month ago
Fr AQUILA study: #Uveitis status in AS or PsA pts given SEC
👁🗨3 pts w/o uveitis at BL developed new onset uveitis during study
👁🗨Most pts w/uveitis at BL - status remained unchanged or improved
👁🗨SEC did not ⬆ risk of uveitis
@RheumNow #ACR21 abs1738 https://t.co/IGUpgXBLvt
Olga Petryna DrPetryna
3 years 1 month ago
Abst1632 #ACR21 #ACRBest @RheumNow 25 children w/ uSAID & MEFV mutations: E148Q mutation standouts-32% heterozygous for E148Q, Asian ancestry seen in 37% kids w/ E148Q. E148Q assoc w/longer febrile episodes& less likely to have a full response to colchicine (25% vs 70%; p = 0.03) https://t.co/Rst6KHntPD
Robert B Chao, MD doctorRBC
3 years 1 month ago
Predictor of PsO transition to PsA?
Age - pts dx with PsO at 42 developed PsA 12 years sooner than pts dx at 18
Abs#1798
#ACR21 @RheumNow
https://t.co/1zTifI3H1V https://t.co/MVP8VWicyS
Olga Petryna DrPetryna
3 years 1 month ago
Abst1773 #ACR21 @rheumnow guselkumab outperforms ustekinumab in both msk & skin domains in bio naive & bio experienced alike- data from pivotal Phase III trials : at weeks 52 GUS better ACR20, PASI100 in both doses vs Stelara https://t.co/lfddaCJA5O
Eric Dein ericdeinmd
3 years 1 month ago
#ACR21 Thieves: SLE and SSc with worsening cytopenia and hematuria despite treatment:
Maria Powell - presents overlap case with PNH, responded to eculizumab
@Rheumnow https://t.co/CGvHEMA3lI
Janet Pope Janetbirdope
3 years 1 month ago
Use your good sun screen/blocker. UV radiation is best blocked! Changes beyond skin damage and cancer. Immune activation. @RheumNow #ACR21 #climate change https://t.co/VyCZR5rt8x
Dr. John Cush RheumNow
3 years 1 month ago
Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade
Dr. Chan ( @synovialjoints) interviews Dr. Ziade about abstract #1787 presented at the #ACR21 annual meeting.
https://t.co/Sdd1HHKRib https://t.co/ynRocjviVu
Richard Conway RichardPAConway
3 years 1 month ago
Meta-analysis of PUFA supplementation in RA. Apparent benefits across most measures, albeit often small. Abstr#1682 #ACR21 @RheumNow https://t.co/1rGhpqvJvp
Richard Conway RichardPAConway
3 years 1 month ago
No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthritis, enthesitis, dactylitis, skin, QoL or function. Abstr#L12 #ACR21 @RheumNow https://t.co/iojKLqRb06
TheDaoIndex KDAO2011
3 years 1 month ago
Watch my interview w/incredible rheum leaders in the field of aging:
👉🏼what inspired them
👉🏼changes we need to make in our practice
👉🏼end of life care (including MD-assisted suicide).
#BetterThanNPR
#ACR21 @RheumNow
@UnaMakris
https://t.co/RBfvgHEkpm via @YouTube